- Home
- NTB vs NEO Comparison
NTB vs NEO Comparison
Compare NTB & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NTB | NEO |
|---|---|---|
| Founded | 1858 | 2001 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2016 | 2008 |
Fundamental Metrics
Financial Performance| Metric | NTB | NEO |
|---|---|---|
| Price | $58.75 | $16.60 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $53.75 | $13.38 |
| AVG Volume (30 Days) | 179.7K | ★ 2.3M |
| Earning Date | 04-28-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.66% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.84 | $10.63 |
| Revenue Next Year | $4.16 | $9.73 |
| P/E Ratio | $9.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $40.59 | $6.24 |
| 52 Week High | $64.17 | $16.92 |
Technical Indicators
Market Signals| Indicator | NTB | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 35.41 | 57.82 |
| Support Level | $57.71 | $11.49 |
| Resistance Level | $61.11 | $16.92 |
| Average True Range (ATR) | 1.14 | 0.56 |
| MACD | -0.47 | -0.07 |
| Stochastic Oscillator | 0.00 | 55.70 |
Price Performance
Historical ComparisonAbout NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It offers banking services, comprising retail and corporate banking, and wealth management services, which consist of trust, private banking, and asset management business. The company operates through four reportable segments: Bermuda, Cayman, Channel Islands and the UK, and Other. In its Bermuda and Cayman segments, the company offers retail banking and wealth management services. In the Channel Islands and the UK segment, the company offers retail and corporate banking and wealth management services, and the Other segment includes its operations in the Bahamas, Canada, Mauritius, Singapore, and Switzerland. Maximum revenue for the company is generated from its business in Bermuda.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.